CEACAM5 and cancer: The rational integration of dissolution enhanced luminescent bioassay strategy and miniaturized detection device enables the unique lab‐in‐syringe assay of tumor marker like carcinoembryonic antigen (CEA, an important tumor marker in clinic diagnosis and prognosis of cancer) with a detection limit down to 1.47 pg mL−1 (7.35 × 10−15m).